Parrains et Partenaires

The Society for AIDS in Africa (SAA) was established in Kinshasa in October 1990 during the 5th International Conference on AIDS and Associated Cancers in Africa, a precursor to the International Conference on AIDS and STIs in Africa (ICASA).

The formation of SAA with the support of the World Health Organization (WHO) brought to an end, the practice of organizing the International Conference on AIDS in Africa, outside the African continent. At the same time, it empowered Africans to address and respond to the challenges posed by HIV/AIDS on the continent.

The SAA envisions an HIV free Africa with capacity to confront HIV/AIDS and its consequences as well as its related diseases (such as Tuberculosis and Malaria).

The Society also promotes positive environment and research on HIV and its related diseases. The SAA is governed by an Executive Council drawn from South, North, East, West and Central Africa.

SAA partners and collaborates with range of NGOs and it enjoys the support of the UN-System, as well as various International organizations, including the International AIDS Society (IAS). The Society for AIDS in Africa, is the organizer of ICASA. The next ICASA will be organized in 2023. The host country will be announced soon.

UNAIDS leads the global effort to end AIDS as a public health threat by 2030 as part of the United Nations Sustainable Development Goals.

It provides the strategic direction, advocacy, coordination and technical support to catalyse and connect governments, the private sector and communities to deliver life-saving HIV services. UNAIDS provides the most extensive data collection on HIV epidemiology, programme coverage and finance and publishes the most authoritative and up-to-date information on the epidemic—vital for an effective HIV response.

UNAIDS draws on the experience and expertise of 11 United Nations system cosponsors, with civil society represented on its governing body.

The WHO Regional Office for Africa (WHO/AFR) is one of WHO’s six regional offices around the world. It serves the WHO African Region, covering 47 countries comprising all sub-Sahara African countries and Algeria. Dedicated to the well-being of people and guided by science, the World Health Organization leads and champions efforts to give everyone in the region, an equal chance at a safe and healthy life. We are the UN agency for health that connects nations, partners, and people across the region, leading the response to health emergencies, preventing disease, addressing the root causes of health issues and expanding access to medicines and health care. Our mission is to promote health, keep the world safe and serve the vulnerable. More at www.afro.who.int

UNFPA is the United Nations sexual and reproductive health agency. Our mission is to deliver a world where every pregnancy is wanted, every childbirth is safe and every young person's potential is fulfilled. We promote gender equality and empower women, girls and young people to take control of their bodies and their futures. We work with partners in more than 150 countries to provide access to a wide range of sexual and reproductive health services. Our goal is ending unmet need for family planning, preventable maternal death, and gender-based violence and harmful practices including child marriage and female genital mutilation by 2030.

Viatris Inc. (NASDAQ: VTRS) is a global healthcare company empowering people worldwide to live healthier at every stage of life. We provide access to medicines, advance sustainable operations, develop innovative solutions and leverage our collective expertise to connect more people to more products and services through our one-of-a-kind Global Healthcare Gateway®. Formed in November 2020, Viatris brings together scientific, manufacturing and distribution expertise with proven regulatory, medical, and commercial capabilities to deliver high-quality medicines to patients in more than 165 countries and territories. Viatris' portfolio comprises more than 1,400 approved molecules across a wide range of therapeutic areas, spanning both non-communicable and infectious diseases, including globally recognized brands, complex generic and branded medicines, and a variety of over-the-counter consumer products. Find out more at Viatris.com

At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine.

Our focus goes beyond medicines, and we also strive to remedy health inequities and break down barriers to care. We empower our people to tackle these challenges, and we’re all united in our commitment to help millions of people live healthier lives.

Company Overview

The Global Fund is a partnership to defeat HIV, TB and malaria and ensure a healthier, safer, more equitable future for all.

We raise and invest US$4billion a year to fight the deadliest infectious diseases, challenge the inequity which fuels them and strengthen health systems in more than 100 countries.

We unite world leaders, communities, civil society, health workers and the private sector to find out what works and take it to scale – so the world makes more progress, more rapidly.

It’s working. Since 2002, we have saved 50 million lives. We won’t stop until the job is finished.

For more than 35 years, MSD has been committed to scientific research and discovery (R&D) in HIV. Today, we are developing a series of antiviral options designed to help people manage HIV and protect people from HIV, with the goal of reducing the growing burden of infection worldwide. We remain committed to working hand-in-hand with our partners in the global HIV community to address the complex challenges that impede progress toward ending the epidemic. For more information, visit www.merck.com and connect with us on Twitter, Facebook, Instagram, YouTube and LinkedIn.

ViiV Healthcare is a global specialist pharmaceutical company 100% dedicated to HIV medicines and research and focused on people living with HIV and AIDS. Born out of a partnership between GSK and Pfizer in 2009, with Shionogi joining in 2012, at ViiV Healthcare we are determined to help end the HIV epidemic. From our unique origins to our innovative medicines, we push the boundaries of what people think is possible in HIV treatment and care. Our one focused goal unites our employees located across the globe, with their expertise in research, manufacturing, policy and more, all guided by our mission to be here until HIV isn’t.

Visit www.viivhealthcare.com to find out more about who we are, what we do and how we do it.

Abbott is a global leader in in vitro diagnostics with one of the broadest portfolios of businesses spanning nearly every segment – point of care, immunoassay, clinical chemistry, hematology, blood screening, molecular, and informatics. Abbott’s life-changing tests and diagnostic tools provide accurate, timely information to better manage health. We’re empowering smarter medical and economic decision making to help transform the way people manage their health at all stages of life.

The Children’s Investment Fund Foundation (CIFF) is one of the world’s largest independent funders of children, with offices in Addis Ababa, Beijing, London, Nairobi, and New Delhi.

Established in 2002, CIFF’s mission is to create a world where every child can live a healthy, fair and safe life. With a rigorous and evidence-driven mindset, CIFF supports bold interventions that focus on making systemic change. This includes programmes on child health, sexual and reproductive health and rights, opportunities for girls and young women, as well as tackling the climate emergency.

Hologic is an innovative medical technology company primarily focused on improving women’s health and well-being through early detection and treatment. We deliver life-changing and life-saving detection, diagnostic and surgical innovations that are rooted in science, driven by technology and inspired by a desire to improve the health of women and families around the world.

While we focus on women’s health and well-being, we are committed to having an even broader benefit for the world. Together, we advocate for better health and wellness through solutions that provide ever greater certainty and peace of mind.

Satewave Technologies was founded in 2008 as a comprensive solution provider , mainly engaged in health sector ,IT sector,telecommunications , smart city , internet of things ,photovaitic sector, products and services. Our main customers are government departments and state owned enterprises for example ministry of health providing health equipment and medicals and private organisations. With the core values of innovation, customer orientation and excellent quality, we are committed to provide efficient customized solutions and establishing long term partnership with customers, through our skilled team members.

Avacare is a leading healthcare organization dedicated to improving access to quality healthcare services in Africa. With a strong focus on innovation, Avacare aims to create sustainable healthcare solutions that address the unique challenges faced by the African population and beyond. Established in 1996, Avacare Health has developed a significant footprint across Africa, emerging as a prominent player in the healthcare industry. With a formidable presence in 22 countries, the company has grown exponentially, boasting a workforce of 1500 employees dedicated to delivering quality healthcare solutions. Avacare Health’s extensive network includes 47 sales offices, 15 manufacturing sites, and 25 warehouses, strategically positioned to efficiently serve the continent's diverse healthcare needs. With a product portfolio of over 2500 healthcare solutions, the company caters to a vast array of medical requirements, touching the lives of over 600 million people in Africa. Notably, the establishment of Afrigen, the mRNA Hub in Cape Town and FARMOVS, a cutting-edge clinical research facility further highlights Avacare Health's commitment to innovation and advancing medical breakthroughs, solidifying its influential impact on healthcare throughout the region.

UNICEF works in the world’s toughest places to reach the most disadvantaged children and adolescents – and to protect the rights of every child, everywhere. Across more than 190 countries and territories, UNICEF does whatever it takes to help children survive, thrive and fulfil their potential, from early childhood through adolescence. Before, during and after humanitarian emergencies, UNICEF is on the ground, bringing lifesaving help and hope to children and families. Non-political and impartial, UNICEF is never neutral when it comes to defending children’s rights and safeguarding their lives and futures.

Chemonics International Inc. is a development firm with more than 40 years of experience working in more than 150 countries. Chemonics is a trusted implementing partner that is committed to solving the world’s toughest development challenges with multidisciplinary teams working across sectors. Most notably, Chemonics and partners lead the implementation of the USAID Global Health Supply Chain Program-Procurement and Supply Management (GHSC-PSM) project. GHSC-PSM has offices in 35 countries and collaborates with ministries of health (MOHs) to advance and sustain efficient and resilient health supply chains, thereby increasing access to lifesaving health commodities to the people who need it most.